Literature DB >> 21768922

Diagnosis of bacteremia in febrile neutropenic episodes in children with cancer: microbiologic and molecular approach.

María E Santolaya1, Mauricio J Farfán, Verónica De La Maza, Manuela Cociña, Felipe Santelices, Ana M Alvarez, Carmen L Avilés, Ana Becker, Miguel O'Ryan, Paulina Román, Carmen Salgado, Pamela Silva, Santiago Topelberg, Juan Tordecilla, Mónica Varas, Milena Villarroel, Tamara Viviani, Marcela Zubieta, Juan P Torres.   

Abstract

BACKGROUND: Bacterial isolation using conventional microbiologic techniques rarely surpasses 25% in children with clinical and laboratory findings indicative of an invasive bacterial infection. The aim of this study was to determine the role of real-time polymerase chain reaction (RT-PCR) from whole blood samples compared with automated blood cultures (BC) in detection of relevant microorganisms causing bacteremia in episodes of high-risk febrile neutropenia (HRFN) in children with cancer.
METHODS: Children presenting with HRFN at 6 hospitals in Santiago, Chile, were invited to participate. Blood samples were obtained at admission for BC, and at admission and 24 hours for RT-PCR targeting DNA of Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa causing bacteremia in children with HRFN.
RESULTS: A total of 177 HRFN episodes were evaluated from May 2009 to August 2010, of which 29 (16.3%) had positive BC, 9 (5%) positive for 1 of the 3 selected bacterial species: 5 for E. coli, 3 for S. aureus, and 1 for P. aeruginosa. RT-PCR detected 39 bacteria in 36 episodes (20%): 14 E. coli, 20 S. aureus, and 5 P. aeruginosa. The sensitivity, specificity, and positive and negative predictive values of RT-PCR compared with BC were 56%, 80%, 13%, and 97%. The final clinical diagnosis was compatible with an invasive bacterial infection in 30/36 (83%) RT-PCR-positive episodes.
CONCLUSIONS: In our series, RT-PCR significantly improved detection of the most relevant bacteria associated with HRFN episodes. Large number of patients and close clinical monitoring, in addition to improved RT-PCR techniques will be required to fully recommend RT-PCR-based diagnosis for the routine workup of children with cancer, fever, and neutropenia.

Entities:  

Mesh:

Year:  2011        PMID: 21768922     DOI: 10.1097/INF.0b013e31822a37d7

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  5 in total

1.  Multiple Polymerase Chain Reaction for Direct Detection of Bloodstream Infection After Cardiac Surgery in a PICU.

Authors:  Rosa María Calderón Checa; Manuel Gijón; Sylvia Belda Hofheinz; Pablo Rojo
Journal:  Crit Care Explor       Date:  2022-05-27

2.  Multidrug- and Carbapenem-Resistant Pseudomonas aeruginosa in Children, United States, 1999-2012.

Authors:  Latania K Logan; Sumanth Gandra; Siddhartha Mandal; Eili Y Klein; Jordan Levinson; Robert A Weinstein; Ramanan Laxminarayan
Journal:  J Pediatric Infect Dis Soc       Date:  2017-11-24       Impact factor: 3.164

3.  Diagnosis of bacteremia in pediatric oncologic patients by in-house real-time PCR.

Authors:  Milene Gonçalves Quiles; Liana Carballo Menezes; Karen de Castro Bauab; Elke Kreuscher Gumpl; Talita Trevizani Rocchetti; Flavia Silva Palomo; Fabianne Carlesse; Antonio Carlos Campos Pignatari
Journal:  BMC Infect Dis       Date:  2015-07-23       Impact factor: 3.090

4.  Clinical relevance of molecular identification of microorganisms and detection of antimicrobial resistance genes in bloodstream infections of paediatric cancer patients.

Authors:  Fabianne Carlesse; Paola Cappellano; Milene Gonçalves Quiles; Liana Carballo Menezes; Antonio Sérgio Petrilli; Antonio Carlos Pignatari
Journal:  BMC Infect Dis       Date:  2016-09-01       Impact factor: 3.090

5.  Efficacy and safety of withholding antimicrobial treatment in children with cancer, fever and neutropenia, with a demonstrated viral respiratory infection: a randomized clinical trial.

Authors:  M E Santolaya; A M Alvarez; M Acuña; C L Avilés; C Salgado; J Tordecilla; M Varas; M Venegas; M Villarroel; M Zubieta; A Toso; A Bataszew; M J Farfán; V de la Maza; A Vergara; R Valenzuela; J P Torres
Journal:  Clin Microbiol Infect       Date:  2016-11-14       Impact factor: 8.067

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.